CMFRI develops anti-obesity nutraceutical The Hindu dated 28th May 2017

CMFRI, Library (2017) CMFRI develops anti-obesity nutraceutical The Hindu dated 28th May 2017. The Hindu.

[img] Text
The Hindu_28 May 2017.pdf

Download (101kB)
Official URL: http://www.thehindu.com/news/cities/Kochi/cmfri-de...
Related URLs:

    Abstract

    The anti-obesity nutraceutical developed by the Central Marine Fisheries Research Institute (CMFRI) from seaweeds will soon hit the market. The CMFRI has signed a pact with healthcare group VLCC for the commercial production of the product named Cadalmin Antihypercholesterolemic extract (Cadalmin - ACe), a natural remedy for obesity. A. Gopalakrishnan, director of CMFRI, signed a licence agreement with the director and executive vice president of the firm, said a release. Cadalmin was developed using natural marine bioactive ingredients from selected seaweeds.

    Item Type: Other
    Uncontrolled Keywords: Newspaper; News; CMFRI in Media
    Subjects: Library & Information Science
    CMFRI News Clippings
    Divisions: Library & Documentation
    Depositing User: Arun Surendran
    Date Deposited: 05 Jun 2017 09:49
    Last Modified: 05 Jun 2017 09:49
    URI: http://eprints.cmfri.org.in/id/eprint/11918

    Actions (login required)

    View Item View Item